THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.
作者信息
COLMAN R, ALEXANDER B
出版信息
J Clin Invest. 1964 Apr;43(4):705-19. doi: 10.1172/JCI104955.
Abstract
摘要
相似文献
1
THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.
J Clin Invest. 1964 Apr;43(4):705-19. doi: 10.1172/JCI104955.
2
THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.
J Clin Invest. 1964 Apr;43(4):720-7. doi: 10.1172/JCI104956.
3
[Action of neodymium 3-sulfo-isonicotinate on the mechanism of coagulation in guinea pigs and rabbits].
Rev Can Biol. 1967 Mar;26(1):1-9.
4
[BLOOD CLOTTING FACTORS IN RENAL DISEASES].
Nihon Ketsueki Gakkai Zasshi. 1963 Dec;26:767-78.
5
TISSUE EXTRACTS AND THEIR SENSITIVITY TO FACTOR VII AND FACTOR X.
Thromb Diath Haemorrh. 1964 Apr 15;11:146-54.
6
KINETICS OF HUMAN BLOOD COAGULATION INDUCED BY TRYPSIN.
Thromb Diath Haemorrh. 1964 Oct 15;12:307-30.
7
THROMBOPLASTIN FORMATION.
Annu Rev Med. 1964;15:215-32. doi: 10.1146/annurev.me.15.020164.001243.
8
COAGULATION FACTORS IN NEWBORN ANIMALS.
J Lab Clin Med. 1964 May;63:784-90.
9
[EFFECTS OF CHLORTETRACYCLINE ON THE BLOOD COAGULATION PROCESSES].
Cas Lek Cesk. 1963 May 10;102:532-3.
10
OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.
Biochim Biophys Acta. 1964 Aug 19;90:436-9. doi: 10.1016/0304-4165(64)90220-x.
引用本文的文献
1
THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.
J Clin Invest. 1964 Apr;43(4):720-7. doi: 10.1172/JCI104956.
本文引用的文献
1
A LABILE SERUM FACTOR CLOTTING DEFECT: ITS DEMONSTRATION BY THE THROMBOPLASTIN GENERATION TEST AND ITS CLINICAL SIGNIFICANCE.
J Clin Invest. 1961 Jan;40(1):13-22. doi: 10.1172/JCI104225.
2
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
Proc Soc Exp Biol Med. 1952 Apr;79(4):692-4. doi: 10.3181/00379727-79-19488.
3
The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
Scand J Clin Lab Invest. 1951;3(3):201-8. doi: 10.3109/00365515109060600.
4
A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.
J Clin Invest. 1955 Apr;34(4):602-13. doi: 10.1172/JCI103109.
5
THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.
J Clin Invest. 1964 Apr;43(4):720-7. doi: 10.1172/JCI104956.
6
Proteolysis, fibrinolysis, and coagulation. Significance in thrombolytic therapy.
Circulation. 1962 Oct;26:596-611. doi: 10.1161/01.cir.26.4.596.
7
The thrombotic activity of activation product.
J Clin Invest. 1962 Feb;41(2):235-44. doi: 10.1172/JCI104475.
8
The prephase accelerator. Present status.
Thromb Diath Haemorrh. 1961 Sep 1;6:254-60.
9
The role of human coagulation factors in serum-induced thrombosis.
J Clin Invest. 1960 Feb;39(2):262-5. doi: 10.1172/JCI104036.
Zotero 插件